Dottikon ES Holding AG operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dottikon ES Holding AG with three other
pharmaceutical manufacturers in Europe:
sales of 111.28 million Euro [US$120.17 million]
Amarin Corporation PLC
of the United Kingdom
(£96.76 million [US$120.64 million]
of which 100%
was Research&Development), and
based in Bulgaria
(227.87 million Bulgarian Lev [US$125.76 million]
During the year ended March of 2016, sales at
Dottikon ES Holding AG were 121.43 million Swiss Francs (US$122.54 million).
increase of 25.8%
versus 2015, when the company's sales were 96.49 million Swiss Francs.
This was the fifth consecutive year of sales increases at Dottikon ES Holding AG
(and since 2011, sales have increased a total of 52%).
Sales of Pharma Products saw an increase
37.8% in 2016, from
79.07 million Swiss Francs to 108.93 million Swiss Francs.
Not all segments of Dottikon ES Holding AG experienced an increase in sales in 2016:
sales of Fine Chemicals fell 34.4% to 8.95 million Swiss Francs.
Dottikon ES Holding AG also experienced decreases in sales in
Recycling and Waste (down 6.0% to 3.55 million Swiss Francs)